Tue 06/08/2021 23:47 PM
Share this article:
UPDATE 1: 11:47 p.m. ET 6/8/2021: Yestar Healthcare Holdings, in various announcements to the Hong Kong stock exchange, disclosed that it had bought back 2.2 million shares in aggregate from May 20 to June 8 for a total consideration of HKD 2.5 million ($0.3 million), which implies an average price of HKD 1.16, according to Reorg’s calculations.

This brings the total amount of shares bought back by Yestar between the start of 2021 and June 8 to 8.2 million shares, with the company paying a total consideration of HKD 9.4 million -- which implies an average price of HKD 1.16.

Details of the share repurchase transactions are as follows:
 


Original Story 11:04 p.m. UTC on May 18, 2021

Yestar Repurchased 6M Shares From April 8 to May 14 For HK$7M, Average Price of HK$1.16

Relevant Document:
FY’21 Share Buyback Announcements

Yestar Healthcare Holdings, in various announcements to the Hong Kong stock exchange, disclosed that it had bought back 5.97 million shares in aggregate from April 8 to May 14 for a total consideration of HK$6.9 million ($0.9 million), which implies an average price of HK$1.16.

Based on Reorg’s calculations, the amount of shares repurchased represented 0.25% of the company’s 2.35 billion total shares outstanding, after the cancellation of the shares repurchased.

Details of the share repurchase transactions are as follows:
 

According to the full-year 2020 annual report, the company repurchased 15.6 million shares for an aggregate consideration of HK$19.3 million - at an implied average price of HK$1.24 - with details as follows:
 

Reorg’s Tear Sheet highlights that 217.5 million shares beneficially owned by Chairman and CEO, James Hartono, remain pledged to a financial institution to secure a loan granted to Hartono.
 
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2021 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!